Objective To analyze the efficacy of probiotics combined with acupoint application in cancer pain patients with opioid-induced constipation. Methods A total of 92 cancer pain patients with opioid-induced constipation were selected and divided into a control group (n=46, receiving conventional laxative treatment) and a study group (n=46, receiving conventional laxative plus probiotics and acupoint application) using a random number table. Both groups were treated continuously for 4 weeks. The total effective rate, as well as constipation severity (assessed using the Patient Assessment of Constipation-Symptoms [PAC-SYM]), quality of life (assessed using the Patient Assessment of Constipation-Quality of Life [PAC-QOL]), and composition of intestinal microbiota before and after treatment, was compared between the two groups. Results The total effective rate in the study group was higher than that in the control group (91.30% vs 67.39%) (P<0.05). Before treatment, there was no statistically significant difference between the two groups in PAC-SYM factor score (stool consistency, rectal symptoms, or abdominal symptoms), PAC-QOL dimension score (physical discomfort, psychosocial discomfort, worries and concerns, or satisfaction), or counts of Escherichia coli, Bifidobacterium, Enterococcus, and Lactobacillus (all P>0.05). After 4 weeks of treatment, the above scores decreased in both groups, counts of Escherichia coli and Enterococcus decreased, and counts of Bifidobacterium and Lactobacillus increased; moreover, the study group had lower scores, fewer counts of Escherichia coli and Enterococcus, and more counts of Bifidobacterium and Lactobacillus than the control group (all P<0.05). Conclusions Probiotics combined with acupoint application helps alleviate clinical symptoms, improve intestinal microbiota imbalance, and promote quality of life in cancer pain patients with opioid-induced constipation, demonstrating significant clinical efficacy.